MEDIOS AGO.N. news, videos and press releases
For more news please use our advanced search feature.
MEDIOS AGO.N. - More news...
MEDIOS AGO.N. - More news...
- EQS-Adhoc: Medios AG: Specification of the full-year forecast
- EQS-News: Medios AG reports record quarter Q3 2024 with significant increase in earnings and margins
- EQS-News: Medios AG: Annual General Meeting resolves to expand the Supervisory Board to five members
- EQS-News: Medios AG continues its growth trajectory in the first half of 2024 and records disproportionately high increase in earnings
- EQS-News: Medios expands „Advanced Therapies“ field and appoints Dr. Andreas Schmiede as Vice President
- “Hauptstadtkongress 2024”: Medios hosts symposium on 'Security of supply”
- EQS-News: Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A.
- EQS-News: Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00
- EQS-News: Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
- EQS-News: Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance
- EQS-News: Medios AG: Constantijn van Rietschoten appointed Executive Board member for International Markets
- EQS-News: Medios achieves double-digit growth in 2023 – Positive outlook for 2024
- EQS-News: Medios acquires Dutch market leader in pharmaceutical compounding services
- EQS-Adhoc: Medios acquires Dutch market leader in pharmaceutical compounding services
- EQS-News: Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit
- EQS-News: Medios records strongest quarter in the Company's history
- EQS-News: Medios AG: Strong operating cash flow – record figures as expected also for revenue and earnings in the third quarter of 2023
- EQS-News: Medios AG: achieves further growth in the first half of 2023 and expects strong third quarter
- EQS-News: Medios AG: Annual General Meeting re-elects Dr. Yann Samson, Joachim Messner and Klaus J. Buß to the Supervisory Board
- EQS-News: Medios AG centralizes blister business at one site and sells Kölsche Blister GmbH
- EQS-News: Medios AG: Supervisory Board extends contract with Chief Financial Officer Falk Neukirch
- EQS-News: Medios AG: starts successfully into the 2023 financial year
- EQS-News: Medios AG expects continued growth after record year in 2022 and plans further increase in profit margin
- EQS-News: Medios AG: Record revenue and earnings – Guidance 2022 achieved; further growth expected in financial year 2023
- EQS-News: Medios AG: Successful completion of the acquisition of bbw – Significant expansion of compounding volume
- EQS-News: Medios AG presents growth strategy and announces medium-term targets at Capital Markets Day 2022
- EQS-Adhoc: Medios AG: Acquisition of Blisterzentrum Baden-Württemberg GmbH and expansions in the area of sterile manufacturing
- EQS-News: Medios AG continues growth course in the first nine months of 2022 – guidance for the 2022 financial year confirmed
- EQS-News: Medios AG significantly expands compounding capacity at Berlin site – manufacturing permit granted for new laboratory
- DGAP-News: Medios AG continues record course: Strong growth in the first half of 2022
